Molybdocene dichloride

Molybdocene dichloride
Names
IUPAC name
dichlorobis(η5-cyclopentadienyl)molybdenum(IV)
Other names
molybdocene dichloride,
molybdenocene dichloride,
dichloridobis(cyclopentadienyl)molybdenum(IV)
Identifiers
12184-22-4
ChemSpider 398274
Jmol interactive 3D Image
PubChem 452153
Properties
C10H10Cl2Mo
Molar mass 297.04 g·mol1
Appearance greenish-brown powder
insoluble, moisture sensitive
Hazards
Safety data sheet [1]
Related compounds
Related compounds
Ferrocene
Zirconocene dichloride
Vanadocene dichloride
Niobocene dichloride
Titanocene dichloride
Tantalocene dichloride
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references

Molybdocene dichloride is the organomolybdenum compound with the formula (η5-C5H5)2MoCl2 and IUPAC name dichlorobis(η5-cyclopentadienyl)molybdenum(IV), and is commonly abbreviated as Cp2MoCl2. It is a brownish-green air- and moisture-sensitive powder. In the research laboratory, it is used to prepare many derivatives.

Preparation and structure

The compound was first reported in 1964 by Malcolm Green and his student Cooper.[2] It is prepared from molybdocene dihydride, which in turn is prepared by a famously complex reaction involving molybdenum pentachloride, sodium cyclopentadienide, and sodium borohydride. The dihydride converts to the dichloride upon treatment with chloroform:[3]

(C5H5)2MoH2 + 2 CHCl3 → (C5H5)2MoCl2 + 2 CH2Cl2

The compound adopts a "clamshell" structure where the Cp rings are not parallel, the average Cp(centroid)-M-Cp angle being 130.6°. The two chloride ligands are cis, the Cl-Mo-Cl angle of 82° being narrower than in niobocene dichloride (85.6°), which in turn is less than in zirconacene dichloride (92.1°). This trend helped to establish the orientation of the HOMO in this class of complex.[4]

Uses

Unlike the titanocene and zirconacene derivatives, the molybddocene compounds have yielded no commercial applications.

All metallocene dihalides exhibit some anti-cancer activity,[5] but these have not yielded useful compounds in the clinic.[6]

References

  1. "42-0100 Molybdenum " Bis(cyclopentadienyl)molybdenum dichloride, 99%". Strem Chemicals. 27 July 2011. Retrieved 5 February 2012.
  2. R. L. Cooper and M. L. H. Green, Z. Naturforsch., B: Anorg. Chem. Org. Chem. 1964, volume 19, pp. 652. R. L. Cooper and M. L. H. Green, J. Chem. Soc. (A), 1967, p. 1155.
  3. Silavwe, Ned D.; Castellani, Michael P.; Tyler, David R. (1992). "Bis(η5-Cyclopentadienyl)Molybdenum(IV) Complexes". Inorganic Syntheses 29: 204–211. doi:10.1002/9780470132609.ch50.
  4. K. Prout, T. S. Cameron, R. A. Forder, and in parts S. R. Critchley, B. Denton and G. V. Rees "The crystal and molecular structures of bent bis-π-cyclopentadienyl-metal complexes: (a) bis-π-cyclopentadienyldibromorhenium(V) tetrafluoroborate, (b) bis-π-cyclopentadienyldichloromolybdenum(IV), (c) bis-π-cyclopentadienylhydroxomethylaminomolybdenum(IV) hexafluorophosphate, (d) bis-π-cyclopentadienylethylchloromolybdenum(IV), (e) bis-π-cyclopentadienyldichloroniobium(IV), (f) bis-π-cyclopentadienyldichloromolybdenum(V) tetrafluoroborate, (g) μ-oxo-bis[bis-π-cyclopentadienylchloroniobium(IV)] tetrafluoroborate, (h) bis-π-cyclopentadienyldichlorozirconium" Acta Crystallogr. 1974, volume B30, pp. 2290–2304. doi:10.1107/S0567740874007011
  5. Roat-Malone, R. M. (2007). Bioinorganic Chemistry: A Short Course (2nd ed.). John Wiley & Sons. pp. 1920. ISBN 978-0-471-76113-6.
  6. Waern, J. B.; Dillon, C. T.; Harding, M. M. (2005). "Organometallic Anticancer Agents:  Cellular Uptake and Cytotoxicity Studies on Thiol Derivatives of the Antitumor Agent Molybdocene Dichloride". J. Med. Chem. 48 (6): 20932099. doi:10.1021/jm049585o.
Wikimedia Commons has media related to Molybdocene dichloride.
This article is issued from Wikipedia - version of the Sunday, February 14, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.